Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Enso Discoveries, LLC is Excited to Announce the Launch of a Human Health Division-Enso Doctors-Led by Newly Appointed VP of Human Health, Jim Long, MT (ASCP)

Enso Discoveries is very excited to announce the hiring of Jim Long, MT (ASCP) as Vice President of Human Health to help launch Enso Doctors, a Human Division, including a full R&D pipeline and initial product offering of the patent pending Platelet Rich Plasma kit, Rebound PRP™.


News provided by

Enso Discoveries, LLC

Jun 16, 2020, 11:00 ET

Share this article

Share toX

Share this article

Share toX

Jim Long, VP of Human Health Division, Enso Discoveries, LLC and head of Enso Doctors
Jim Long, VP of Human Health Division, Enso Discoveries, LLC and head of Enso Doctors

MANHATTAN, Kan., June 16, 2020 /PRNewswire-PRWeb/ -- Enso Discoveries, LLC is very excited to announce the launch of Enso Doctors, a Human Division, and the hiring of Jim Long, MT (ASCP) as Vice President of Human Health. With a full R&D pipeline Enso Doctors will initially be offering the patent-pending Platelet Rich Plasma kit, Rebound PRP™. The goal of these new products is to offer the latest in quality, easy to use, all inclusive kits with exceptional value and no capital required in most cases. This will allow many more physicians the ability to afford to participate with this promising regenerative therapy.

Enso Doctors utilizes the extensive experience Enso Discoveries, LLC has in regenerative medicine, led by Chief Scientific Officer, Dr. Corey Orava – a regenerative medicine expert – along with our consulting pathologist and excellent university relationships. We design, patent and validate all of our own unique products.

As a board-certified Anesthesiologist and board-certified Pain Management physician, I am thrilled to be able to offer Enso Doctors medical grade Rebound PRP kits as an alternative to routine steroid injections or long-term pain meds, whenever possible.

Post this

"We knew our kits would be great for physicians. Judging by the success we have seen and heard from the current group of physicians using our products we know we can add great value to those that are reluctant to invest in large PRP packages and commit capital, but want to improve their service offerings," explains CEO of Enso Discoveries, LLC, Patrick Farley.

"I've used many other kits with an average price of a PRP kit, with any volume, approaching $180-$250 each and an investment of several thousand dollars in a centrifuge, before I was asked to try the Enso Doctors Rebound PRP kit. I also only need just one of the Enso kits typically to complete my total injections, where with others I often require two or more. This is now the only kit we will use in my practice. Nowhere else can you get this type of quality, volume, shelf life and complete all inclusive sterile kit for this price." – Dr. Ekwensi Griffith, DO.

"As a board-certified Anesthesiologist and board-certified Pain Management physician, I am thrilled to be able to offer Enso Doctors medical grade Rebound PRP kits as an alternative to routine steroid injections or long-term pain meds, whenever possible. When my patients are given an alternative, they often choose PRP. Rebound PRP combines state-of-the-art regenerative medicine science with simplicity and affordability." – Dr. Steven Peloquin, MD

Jim Long, MT (ASCP) the newly appointed Vice President assigned to launch and manage the Enso Doctors Human Health Division, comes to Enso Discoveries with years of sales and management experience in the human side. Jim started out his career as a Med-Tech working in the laboratory. After successfully doing this, he felt his personality and technical ability would be put to better use selling, where he became an award-winning leader with multiple achievements for his time with Abbott Laboratories and several other leading global medical companies.

"When I was approached by Patrick Farley, the CEO of Enso Discoveries, about launching this new division and working for Enso Doctors, I was beyond impressed with the experts he had brought together for his team, and the lengths he has gone to ensure a quality, proven product is delivered. After testing Enso Doctors kits against potential competition at a major university with excellent results and then talking to current Enso PRP users, I was blown away." – Jim Long, MT (ASCP) VP of Human Health, Enso Discoveries, LLC.

"If you are currently using PRP or have interest in trying Rebound PRP, Enso Doctors is offering the ability to simply try just one kit, or multiple kits, as it's totally up to you. We think having to lock into an expensive package or monthly minimum, keeps many from utilizing this amazing product in their practice." – Patrick Farley.

Enso Discoveries, LLC is a biotech company focused on enhancing the lives of humans and animals through the development of relevant, cost-effective, novel technology that allows our valued customer, the physician, to keep their hard-earned business in house. We support our products and services with scientific proof, national distribution partners, and a worldwide network of industry experienced contacts. Ask your medical products distributor about Enso Discoveries, LLC products such as Rebound PRP™ and Rebound PRF® or learn more at http://www.ensodoctors.com.

SOURCE Enso Discoveries, LLC

Related Links

http://www.ensodiscoveries.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.